Cargando…
Glioblastoma, from disease understanding towards optimal cell-based in vitro models
BACKGROUND: Glioblastoma (GBM) patients are notoriously difficult to treat and ultimately all succumb to disease. This unfortunate scenario motivates research into better characterizing and understanding this disease, and into developing novel research tools by which potential novel therapeutics and...
Autores principales: | Boccellato, Chiara, Rehm, Markus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424171/ https://www.ncbi.nlm.nih.gov/pubmed/35763242 http://dx.doi.org/10.1007/s13402-022-00684-7 |
Ejemplares similares
-
Sensitization of glioblastoma cells to TRAIL-induced apoptosis by IAP- and Bcl-2 antagonism
por: Lincoln, Frank A., et al.
Publicado: (2018) -
Marizomib sensitizes primary glioma cells to apoptosis induced by a latest-generation TRAIL receptor agonist
por: Boccellato, Chiara, et al.
Publicado: (2021) -
Towards an advanced cell-based in vitro glioma model system
por: Mikhailova, Valeriia, et al.
Publicado: (2018) -
Optimizing T Cell-Based Therapy for Glioblastoma
por: Karachi, Aida, et al.
Publicado: (2021) -
In Vitro Glioblastoma Models: A Journey into the Third Dimension
por: Paolillo, Mayra, et al.
Publicado: (2021)